US2014316154A1PendingUtilityA1
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
Assignee: CERENIS THERAPEUTICS HOLDING SAPriority: Mar 15, 2013Filed: Mar 14, 2014Published: Oct 23, 2014
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
Inventors:Daniela Carmen OniciuStefan HeckhoffBenoit OswaldPeter RebmannAndreas PeerMiguel GonzalezPatrik Sauter
C07F 9/10C07C 231/12C07F 9/141Y02P20/55C07C 249/02C07C 231/10C07F 9/113C07C 233/18C07C 215/24C07C 231/02C07C 213/08C07B 2200/07
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method for synthesizing N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, comprising removing the trityl group of N-palmitoyl-1-O-trityl-3-O-benzoyl-D-erythro-sphingosine under conditions effective to yield N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, wherein the method yields less than about 1% N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine by weight of N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine.
22 . The method of claim 21 , comprising performing the following steps prior to removing the trityl group:
allowing D-erythro-sphingosine to react with palmitic acid in the presence of O-benzotriazole-N,N,N′,N′-tetramethyl-uronium-hexafluoro-phosphate under conditions effective to yield N-palmitoyl-D-erythro-sphingosine; allowing N-palmitoyl-D-erythro-sphingosine to react with a tritylating reagent under conditions effective to yield N-palmitoyl-1-O-trityl-D-erythro-sphingosine; and allowing N-palmitoyl-1-O-trityl-D-erythro-sphingosine to react with a benzoylating reagent under conditions effective to yield N-palmitoyl-1-O-trityl-3-O-benzoyl-D-erythro-sphingosine.
23 . A method for synthesizing N-palmitoyl-D-erythro-sphingomyelin, comprising performing the method of claim 21 and:
allowing N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine to react with 2-chloro-2-oxo-1,3,2-dioxaphospholane under conditions effective to yield N-palmitoyl-3-O-benzoyl-D-erythro-1-O-(2-oxo-1,3,2-dioxaphospholane)-sphingosine;
allowing N-palmitoyl-3-O-benzoyl-D-erythro-1-O-(2-oxo-1,3,2-dioxaphospholane)-sphingosine to react with trimethylamine under conditions effective to yield N-palmitoyl-3-O-benzoyl-D-erythro-sphingomyelin; and
removing the benzoyl group of N-palmitoyl-3-O-benzoyl-D-erythro-sphingomyelin under conditions effective to yield N-palmitoyl-D-erythro-sphingomyelin.
24 . The method of claim 23 , comprising performing the following steps prior to removing the trityl group:
allowing D-erythro-sphingosine to react with palmitic acid in the presence of O-benzotriazole-N,N,N′,N′-tetramethyl-uronium-hexafluoro-phosphate under conditions effective to yield N-palmitoyl-D-erythro-sphingosine; allowing N-palmitoyl-D-erythro-sphingosine to react with a tritylating reagent under conditions effective to yield N-palmitoyl-1-O-trityl-D-erythro-sphingosine; and allowing N-palmitoyl-1-O-trityl-D-erythro-sphingosine to react with a benzoylating reagent under conditions effective to yield N-palmitoyl-1-O-trityl-3-O-benzoyl-D-erythro-sphingosine.
25 . The method of claim 24 , wherein N-palmitoyl-D-erythro-sphingomyelin is synthesizable at an about 1 to about 50 kilogram scale.
26 . A composition comprising N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine and N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, wherein the weight ratio of the N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine to the N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine is about 10:90.
27 . A composition comprising N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine and N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, wherein the weight ratio of the N-palmitoyl-1-O -benzoyl-D-erythro-sphingosine to the N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine is about 5:95.
28 . A composition comprising N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine and N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, wherein the weight ratio of the N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine to the N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine is about 2:98.
29 . A composition comprising N-palmitoyl-1-O-benzoyl-D-erythro-sphingosine and N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine, wherein the weight ratio of the N-palmitoyl-1-0-benzoyl-D-erythro-sphingosine to the N-palmitoyl-3-O-benzoyl-D-erythro-sphingosine is about 1:99.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.